Featured Posts
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
Search Posts
News Release
New Study Debunks Myths About Bottled Water
Recent activist campaigns against bottled water have been filled with myths and half-truths, and have been motivated more by environmentalist ideology than evidence, according to a new study released…
Newsletter
Gregg Withdraws, Health Care Rationing and the ‘Climate Crisis’
Sen. Judd Gregg withdraws his nomination to be President Obama’s Secretary of Commerce. An obscure provision in the federal stimulus bill could lead to health…
News Release
CEI Unveils Agenda for Congress
Washington, D.C., January 26, 2009—With the incoming Obama administration and the opening of the new Congress, the House and Senate are…
Newsletter
The FCC and Media Ownership, Ford’s Auto Bailout and Vilsack for Agriculture
President-elect Obama’s pick to head the Federal Communications Commission favors stronger diversity and “media ownership” regulations. Poor sales figures may push the Ford Motor Company…
News Release
Statement on Nomination of Tom Vilsack to be Agriculture Secretary
Washington, D.C., January 13, 2008—President-elect Obama’s choice for Agriculture Secretary has a troubling record on agriculture and consumer issues, according to an…
Newsletter
Kids’ Safety, The War on Obesity and Che’s Legacy
New safety rules for children’s clothes generate controversy. Massachusetts Gov. Deval Patrick launches a new anti-obesity campaign. Director Steven Soderbergh prepares to release his two-part…
Op-Eds
Time for a Surgeon General-ectomy?
President-elect Obama has reportedly chosen Sanjay Gupta, CNN’s chief medical correspondent and one of People magazine’s “sexiest men alive,” for the post of…
Newsletter
Bailout Fallout, the New (Green) Deal and Scaring Parents with Toxic Arguments
The House and Senate agree on a $700 billion financial bailout bill. Environmentalists try to leverage the mortgage and Wall Street financial crisis to argue…
Citation
the presidential candidates’ views on the biotech industry
Citation
FDA approval for “biogeneric” drugs
Op-Eds
Activists Hit the (Plastic) Bottle Again
Anti-chemical activists opened a new front in their jihad against the plastics chemical bisphenol-A (BPA) this week.
Newsletter
Stem Cells, Regulating Lawn Mowers and Standing up to the SEC
The National Academy of Sciences argues for continued use of embryonic stem cells. The Environmental Protection Agency requires that new gas-powered lawn mowers come with…
Newsletter
Economic Projections, Comcast Sues the FCC and Cholesterol Drugs
A new report from the Federal Reserve projects continued slow growth and a weak business climate. Comcast sues the Federal Communications Commission over…
Newsletter
Stem Cells, Mad Cow Disease and Cuba’s Police
Scientists hail a new breakthrough in stem cell research. A federal Appeals Court rules that the U.S. Department of Agriculture can forbid private meat packers…
Op-Eds
Cholesterol Drug Scare Shenanigans
Why is the editor of the New England Journal of Medicine encouraging a cancer scare over the cholesterol-lowering drug Vytorin? Is he overcompensating for past…
News Release
Public Funding for Stem Cell Research: Boon or Boondoggle?
Debates over the ethics of research using human embryonic stem cells continue long after the Bush Administration’s ban on federal tax-funding for such research. But,…
Study
Public Stem Cell Research Funding
The best way to make progress in stem cell research is to allow the private sector to grow, unimpeded by regulation and controversy.
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…
Study
FDA’s Bad Medicine
How the dispersed knowledge problem affects drug safety analysis and how markets and technology will help patients…
Newsletter
Costs of Regulation, FDA Reform and Global Warming Skepticism
The House Small Business Committee hears testimony on the costs of federal regulation. Patient advocates urge lawmakers to pass legislation forcing the Food and Drug…
Citation
Telling McDonald’s it can open franchises only in the white part of town
Newsletter
FCC Takes on Comcast, GM Crops and the Housing Bailout
The Federal Communications Commission puts Comcast in the hot seat over its network management practices. Security becomes the number one cost for scientists developing genetically…
Newsletter
Environmentalism, Vioxx and Carbon Offsets
The Washington Examiner editorializes on how environmental policies expand the scope of government power. Merck wins two appeals in lawsuits related to its painkiller Vioxx.
Newsletter
Gas Prices, Farm Subsidies and Vioxx Lawsuits
Oil company executives are grilled on high gas prices by members of the Senate Judiciary Committee. Congress prepares to override President Bush’s veto of the…
Newsletter
Gas Prices, DEA and Telephone Trends
The AAA reports that record high gas prices might soon begin to fall. CEI launches the “Politics of Pain” campaign to end harassment of pain…
News Release
“Politics of Pain” Campaign to Defend Patients’ Rights
CEI fighting for millions of Americans who live in pain because their doctors are afraid of being harassed or arrested by the DEA.
Op-Eds
Junk Science: Schumer Chucks the FDA?
Who needs the Food and Drug Administration? New York Democratic Sen. Chuck Schumer and personal injury lawyers certainly don’t — at least to the extent…
Newsletter
Net Neutrality, Poultry Wars and Disaster Insurance
The House Telecommunications and Internet Subcommittee holds a hearing on proposed rules for “net neutrality.” The European Union refuses to lift a ban on the…
Newsletter
Baby Bottles, Union Conflicts and Credit Card Fees
Wal-Mart announces that it will stop selling baby bottles made with the chemical bisphenol A, or BPA. Members of the California Nurses Association and the…
Newsletter
Environmental Politics, Internet Gambling and Drug Imports
Regnery Publishing releases the new book The Really Inconvenient Truths: Seven Environmental Catastrophes Liberals Don't Want You to Know About--Because They Helped Cause Them. An…
News Release
Are Imports the Solution to High Drug Prices?
With the high cost of pharmaceutical drugs playing a central role in the national debate over health care, many policymakers have endorsed the idea…
Newsletter
Custody Disputes, Food Shortages and Taxi Cab Fares
Over 400 children seized from a polygamous sect in Texas are dispersed to group homes and shelters across the state. Zimbabwe, confronted with high food…
Study
Drug Reimportation’s Dangerous Allure
A Misguided Cost-Control Measure Guaranteed to Harm Patient Care…
Newsletter
The Fed, Biotech Crops and Mortgage Bailouts
Treasury Secretary Henry Paulson officially announces a plan to reform oversight of financial markets. Research into genetically modified crops gets a boost in India. President…
Newsletter
Sarbanes-Oxley, Cancer Drugs and Discrimination Law
The National Law Journal warns that penalties in the Sarbanes-Oxley accounting rules for public companies can extend to individuals and private entities. Drug maker Cephalon…
Study
The Five Dumbest Product Bans
This paper focuses on five clearly absurd product bans that seem to serve no social good.
Newsletter
CEI Daily Update
1. ENVIRONMENT CEI releases a new video contrasting increasing carbon dioxide levels with global temperatures. CEI Expert Available to Comment: Senior Fellow…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Sen. Dianne Feinstein (D-CA) pressures the Environmental Protection Agency to declare carbon dioxide a pollutant. CEI Expert Available…
News Release
Supreme Court Rulings Good for Investors
Washington, D.C., February 20, 2008—The Supreme Court this session has made two important decisions that will greatly benefit investors. Both today’s ruling in LaRue v.
Newsletter
CEI Daily Update
Issues in the News 1. INTERNATIONAL President Bush receives praise for public health aid from crowds on his trip to Africa. CEI Expert Available…
Op-Eds
Where’s the Beef?
It’s not often that American food companies join hands with environmental and consumer activists to call for greater government control over the nation’s food…
Op-Eds
Europe’s Continued Hostility to GM Crops Runs Afoul of Science, WTO
France, Germany, and the United Kingdom may have new leaders who bring the promise overall of better trans-Atlantic relations, but when it comes to the…
News Release
FDA Gives a Thumbs Up to Cloned Milk and Meat
Op-Eds
Vaccine Vindication
The vaccine preservative Thimerosal is not linked with autism, a new study reports. The data also suggest that the dilettante "scientist" Robert F. Kennedy,…
News Release
New Video: Cheers to Repeal Day!
Washington, D.C., December 4, 2007—The Bureaucrash Activist Network is releasing a new video just in time to celebrate the repeal of Prohibition…
Newsletter
Daily Update
Issues in the News 1. BIOTECHNOLOGY Possible regulatory reform at the Food and Drug Administration. CEI Expert Available to Comment: Senior…
Study
Promoting Healthy Biopharmaceutical Competition
Full Document Available in PDF The Hatch-Waxman Act, enacted by Congress 23 years ago,…